Publications by authors named "Alberto Costantini"

Claim this Profile
K
Knowledge mapping and visualization of trends of drug holiday in different solid tumours: A literature review.
Romina Giannini, Andrealuna Ucciero, Alessia Romagnoli, Felice Musicco, Fiorenzo Santoleri, Alberto Costantini

J Oncol Pharm Pract· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Methodological Proposal for Health Technology Assessments: A Case Study on Biosimilar Drugs.
Marilisa Pia Dimmito, Lisa Marinelli, Eleonora Chiara Toto, Giuseppe Di Biase, Ivana Cacciatore, Alberto Costantini

J Mark Access Health Policy· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Felice Musicco, Ruggero Lasala, Fiorenzo Santoleri, Alberto Costantini, Paolo Abrate

Recenti Prog Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Efficacy of Dalbavancin in Real Life: Retrospective Analysis of a Large Monocentric Case Series of Patients Treated for Skin/Soft Tissue and Other Difficult-to-Treat Infections.
Giustino Parruti, Ennio Polilli, Simona Coladonato, Giorgia Rapacchiale, Francesca Trave, Alberto Costantini

Antibiotics (Basel)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The international Hip Outcome Tool 12 questionnaire (iHOT-12): an Italian language cross-cultural adaptation and validation.
Filippo Randelli, Alberto Fioruzzi, Alice Clemente, Alessandra Radaelli, Alessandra Menon, Alberto Costantini

J Orthop Traumatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug utilization and medication adherence for the treatment of psoriatic arthritis: an Italian study.
Fiorenzo Santoleri, Paolo Abrate, Laura Pestrin, Enrico Pasut, Germana Modesti, Alberto Costantini

Glob Reg Health Technol Assess· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence, Persistence, Switching and Costs of Injectable and Oral Therapies for Multiple Sclerosis. Real Life Analysis Over 6 Years of Treatment.
Fiorenzo Santoleri, Ruggero Lasala, Eleononora Berardini, Flavia Vernacchio, Donato Leo, Alberto Costantini

Hosp Pharm· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence, persistence and treatment switching in psoriasis.
Fiorenzo Santoleri, Felice Musicco, Chiara Fulgenzio, Paolo Abrate, Laura Pestrin, Alberto Costantini

Immunotherapy· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Groin Pain Syndrome Italian Consensus Conference update 2023.
Gian N Bisciotti, Raul Zini, Matteo Aluigi, Alessandro Aprato, Alessio Auci, Alberto Costantini

J Sports Med Phys Fitness· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The lack of head-to-head randomised trials and the consequences for patients and national health service: The case of non-small cell lung cancer.
Ruggero Lasala, Alessia Romagnoli, Fiorenzo Santoleri, Valentina Isgrò, Corrado Confalonieri, Alberto Costantini

Eur J Clin Pharmacol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence, persistence and switching rates of apixaban, dabigatran and rivaroxaban in non-valvular atrial fibrillation: a multicentre real-life analysis at 3 years.
Alessia Romagnoli, Fiorenzo Santoleri, Alberto Costantini, Angelora Di Risio

Eur J Hosp Pharm· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicentre study with real-world data of the use of palbociclib in the treatment of breast cancer: Treatment duration correlates with dose reductions.
Felice Musicco, Ruggero Lasala, Fiorenzo Santoleri, Alberto Costantini, Paolo Abrate

J Oncol Pharm Pract· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profile, Healthcare Resource Consumption and Related Costs in ANCA-Associated Vasculitis Patients: A Real-World Analysis in Italy.
Luca Degli Esposti, Melania Dovizio, Valentina Perrone, Chiara Veronesi, Margherita Andretta, Alberto Costantini

Adv Ther· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ADA_ETA_BIO2021: real-world evaluation of adherence, persistence, and cost-effectiveness of originator and biosimilar biologic drugs in the treatment of rheumatoid arthritis: a multicenter study in Italy.
Fiorenzo Santoleri, Ruggero Lasala, Paolo Abrate, Laura Pestrin, Enrico Pasut, Alberto Costantini

Curr Med Res Opin· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication adherence reporting in pivotal clinical trials: overview of oral oncological drugs.
Ruggero Lasala, Fiorenzo Santoleri, Alessia Romagnoli, Paolo Abrate, Felice Musicco, Alberto Costantini

Eur J Hosp Pharm· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Systems across Europe and the US: The Managed Entry Agreements Experience.
Michele Ciulla, Lisa Marinelli, Giuseppe Di Biase, Ivana Cacciatore, Fiorenzo Santoleri, Alberto Costantini

Healthcare (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Resource Consumption and Related Costs in Patients on Antiretroviral Therapies: Findings from Real-World Data in Italy.
Valentina Perrone, Melania Dovizio, Diego Sangiorgi, Margherita Andretta, Fausto Bartolini, Alberto Costantini

Int J Environ Res Public Health· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Available information about paediatric use of onco-haematological drugs authorized by EMA since 2016.
Ruggero Lasala, Fiorenzo Santoleri, Davide Zanon, Alessia Romagnoli, Paolo Abrate, Alberto Costantini

J Oncol Pharm Pract· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence, Persistence, and Effectiveness in Real Life. Multicenter Long-Term Study on the Use of Pirfenidone and Nintedanib in the Treatment of Idiopathic Pulmonary Fibrosis.
Fiorenzo Santoleri, Luigia Auriemma, Antonella Spacone, Stefano Marinari, Fabio Esposito, Alberto Costantini

J Pharm Pract· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing and piloting a communication assessment tool assessing patient perspectives on communication with pharmacists (CAT-Pharm).
Daniela Scala, Sara Mucherino, Francesca Wirth, Valentina Orlando, Piera Polidori, Alberto Costantini

Int J Clin Pharm· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized clinical trials and real life studies: Comparison of baseline characteristics of patients in oral target therapies for renal cell carcinoma.
Ruggero Lasala, Fiorenzo Santoleri, Alessia Romagnoli, Felice Musicco, Paolo Abrate, Alberto Costantini

J Oncol Pharm Pract· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of COVID-19 on chronic therapies: the Pescara (ASL) local health authority experience in Italy.
Alessia Romagnoli, Fiorenzo Santoleri, Alberto Costantini

Curr Med Res Opin· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence and persistence in the use of statins and ezetimibe over 8 years in a real-life study.
Fiorenzo Santoleri, Alessia Romagnoli, Alberto Costantini

Curr Med Res Opin· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence and persistence analysis in patients treated with double antiplatelet therapy (DAPT) at two years in real life.
Alessia Romagnoli, Fiorenzo Santoleri, Alberto Costantini

Patient Educ Couns· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug utilisation pattern over 3 years in the real-world treatment of type II diabetes.
Alessia Romagnoli, Fiorenzo Santoleri, Alberto Costantini

Int J Clin Pract· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis